Yongfeng Yang , Xueyan Jin , Yongjiang Xue , Xue Li , Yi Chen , Ning Kang , Wei Yan , Peng Li , Xiaoge Guo , Binbin Luo , Yan Zhang , Qing Liu , Han Shi , Luwen Zhang , Xi Su , Bing Liu , Lin Lu , Luxian Lv , Wenqiang Li
{"title":"右额叶上回:预测精神分裂症短期疗效的潜在神经影像生物标志物","authors":"Yongfeng Yang , Xueyan Jin , Yongjiang Xue , Xue Li , Yi Chen , Ning Kang , Wei Yan , Peng Li , Xiaoge Guo , Binbin Luo , Yan Zhang , Qing Liu , Han Shi , Luwen Zhang , Xi Su , Bing Liu , Lin Lu , Luxian Lv , Wenqiang Li","doi":"10.1016/j.nicl.2024.103603","DOIUrl":null,"url":null,"abstract":"<div><p>Antipsychotic drug treatment for schizophrenia (SZ) can alter brain structure and function, but it is unclear if specific regional changes are associated with treatment outcome. Therefore, we examined the effects of antipsychotic drug treatment on regional grey matter (GM) density, white matter (WM) density, and functional connectivity (FC) as well as associations between regional changes and treatment efficacy. SZ patients (n = 163) and health controls (HCs) (n = 131) were examined by structural magnetic resonance imaging (sMRI) at baseline, and a subset of SZ patients (n = 77) were re-examined after 8 weeks of second-generation antipsychotic treatment to assess changes in regional GM and WM density. In addition, 88 SZ patients and 81 HCs were examined by resting-state functional MRI (rs-fMRI) at baseline and the patients were re-examined post-treatment to examine FC changes. The Positive and Negative Syndrome Scale (PANSS) and MATRICS Consensus Cognitive Battery (MCCB) were applied to measure psychiatric symptoms and cognitive impairments in SZ. SZ patients were then stratified into response and non-response groups according to PANSS score change (≥50 % decrease or <50 % decrease, respectively). The GM density of the right cingulate gyrus, WM density of the right superior frontal gyrus (SFG) plus 5 other WM tracts were reduced in the response group compared to the non-response group. The FC values between the right anterior cingulate and paracingulate gyrus and left thalamus were reduced in the entire SZ group (n = 88) after treatment, while FC between the right inferior temporal gyrus (ITG) and right medial superior frontal gyrus (SFGmed) was increased in the response group. There were no significant changes in regional FC among the non-response group after treatment and no correlations with symptom or cognition test scores. These findings suggest that the right SFG is a critical target of antipsychotic drugs and that WM density and FC alterations within this region could be used as potential indicators in predicting the treatment outcome of antipsychotics of SZ.</p></div>","PeriodicalId":54359,"journal":{"name":"Neuroimage-Clinical","volume":null,"pages":null},"PeriodicalIF":3.4000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2213158224000421/pdfft?md5=de826b1fa71468ce4db71c398ea9df5e&pid=1-s2.0-S2213158224000421-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Right superior frontal gyrus: A potential neuroimaging biomarker for predicting short-term efficacy in schizophrenia\",\"authors\":\"Yongfeng Yang , Xueyan Jin , Yongjiang Xue , Xue Li , Yi Chen , Ning Kang , Wei Yan , Peng Li , Xiaoge Guo , Binbin Luo , Yan Zhang , Qing Liu , Han Shi , Luwen Zhang , Xi Su , Bing Liu , Lin Lu , Luxian Lv , Wenqiang Li\",\"doi\":\"10.1016/j.nicl.2024.103603\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Antipsychotic drug treatment for schizophrenia (SZ) can alter brain structure and function, but it is unclear if specific regional changes are associated with treatment outcome. Therefore, we examined the effects of antipsychotic drug treatment on regional grey matter (GM) density, white matter (WM) density, and functional connectivity (FC) as well as associations between regional changes and treatment efficacy. SZ patients (n = 163) and health controls (HCs) (n = 131) were examined by structural magnetic resonance imaging (sMRI) at baseline, and a subset of SZ patients (n = 77) were re-examined after 8 weeks of second-generation antipsychotic treatment to assess changes in regional GM and WM density. In addition, 88 SZ patients and 81 HCs were examined by resting-state functional MRI (rs-fMRI) at baseline and the patients were re-examined post-treatment to examine FC changes. The Positive and Negative Syndrome Scale (PANSS) and MATRICS Consensus Cognitive Battery (MCCB) were applied to measure psychiatric symptoms and cognitive impairments in SZ. SZ patients were then stratified into response and non-response groups according to PANSS score change (≥50 % decrease or <50 % decrease, respectively). The GM density of the right cingulate gyrus, WM density of the right superior frontal gyrus (SFG) plus 5 other WM tracts were reduced in the response group compared to the non-response group. The FC values between the right anterior cingulate and paracingulate gyrus and left thalamus were reduced in the entire SZ group (n = 88) after treatment, while FC between the right inferior temporal gyrus (ITG) and right medial superior frontal gyrus (SFGmed) was increased in the response group. There were no significant changes in regional FC among the non-response group after treatment and no correlations with symptom or cognition test scores. These findings suggest that the right SFG is a critical target of antipsychotic drugs and that WM density and FC alterations within this region could be used as potential indicators in predicting the treatment outcome of antipsychotics of SZ.</p></div>\",\"PeriodicalId\":54359,\"journal\":{\"name\":\"Neuroimage-Clinical\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2213158224000421/pdfft?md5=de826b1fa71468ce4db71c398ea9df5e&pid=1-s2.0-S2213158224000421-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neuroimage-Clinical\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2213158224000421\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"NEUROIMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuroimage-Clinical","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2213158224000421","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"NEUROIMAGING","Score":null,"Total":0}
引用次数: 0
摘要
抗精神病药物治疗精神分裂症(SZ)可改变大脑结构和功能,但具体的区域变化是否与治疗效果相关尚不清楚。因此,我们研究了抗精神病药物治疗对区域灰质(GM)密度、白质(WM)密度和功能连通性(FC)的影响,以及区域变化与治疗效果之间的关联。在基线时,对SZ患者(163人)和健康对照组(131人)进行结构磁共振成像(sMRI)检查,并在第二代抗精神病药物治疗8周后对部分SZ患者(77人)进行复查,以评估区域GM和WM密度的变化。此外,对88名SZ患者和81名HC患者进行了基线静息态功能磁共振成像(rs-fMRI)检查,并在治疗后对患者进行复查,以检查FC的变化。阳性与阴性综合征量表(PANSS)和MATRICS共识认知测验(MCCB)用于测量SZ患者的精神症状和认知障碍。然后根据PANSS评分的变化(分别为下降≥50%或下降<50%)将SZ患者分为有反应组和无反应组。与无反应组相比,反应组患者右侧扣带回的GM密度、右侧额上回(SFG)的WM密度以及其他5条WM束均有所降低。治疗后,整个 SZ 组(n = 88)中右侧扣带回前部和扣带回旁以及左侧丘脑之间的 FC 值降低,而反应组中右侧颞下回(ITG)和右侧内侧额上回(SFGmed)之间的 FC 值升高。治疗后,无反应组的区域FC无明显变化,与症状或认知测试评分也无相关性。这些研究结果表明,右侧SFG是抗精神病药物的一个关键靶点,该区域的WM密度和FC变化可作为预测SZ抗精神病药物治疗效果的潜在指标。
Right superior frontal gyrus: A potential neuroimaging biomarker for predicting short-term efficacy in schizophrenia
Antipsychotic drug treatment for schizophrenia (SZ) can alter brain structure and function, but it is unclear if specific regional changes are associated with treatment outcome. Therefore, we examined the effects of antipsychotic drug treatment on regional grey matter (GM) density, white matter (WM) density, and functional connectivity (FC) as well as associations between regional changes and treatment efficacy. SZ patients (n = 163) and health controls (HCs) (n = 131) were examined by structural magnetic resonance imaging (sMRI) at baseline, and a subset of SZ patients (n = 77) were re-examined after 8 weeks of second-generation antipsychotic treatment to assess changes in regional GM and WM density. In addition, 88 SZ patients and 81 HCs were examined by resting-state functional MRI (rs-fMRI) at baseline and the patients were re-examined post-treatment to examine FC changes. The Positive and Negative Syndrome Scale (PANSS) and MATRICS Consensus Cognitive Battery (MCCB) were applied to measure psychiatric symptoms and cognitive impairments in SZ. SZ patients were then stratified into response and non-response groups according to PANSS score change (≥50 % decrease or <50 % decrease, respectively). The GM density of the right cingulate gyrus, WM density of the right superior frontal gyrus (SFG) plus 5 other WM tracts were reduced in the response group compared to the non-response group. The FC values between the right anterior cingulate and paracingulate gyrus and left thalamus were reduced in the entire SZ group (n = 88) after treatment, while FC between the right inferior temporal gyrus (ITG) and right medial superior frontal gyrus (SFGmed) was increased in the response group. There were no significant changes in regional FC among the non-response group after treatment and no correlations with symptom or cognition test scores. These findings suggest that the right SFG is a critical target of antipsychotic drugs and that WM density and FC alterations within this region could be used as potential indicators in predicting the treatment outcome of antipsychotics of SZ.
期刊介绍:
NeuroImage: Clinical, a journal of diseases, disorders and syndromes involving the Nervous System, provides a vehicle for communicating important advances in the study of abnormal structure-function relationships of the human nervous system based on imaging.
The focus of NeuroImage: Clinical is on defining changes to the brain associated with primary neurologic and psychiatric diseases and disorders of the nervous system as well as behavioral syndromes and developmental conditions. The main criterion for judging papers is the extent of scientific advancement in the understanding of the pathophysiologic mechanisms of diseases and disorders, in identification of functional models that link clinical signs and symptoms with brain function and in the creation of image based tools applicable to a broad range of clinical needs including diagnosis, monitoring and tracking of illness, predicting therapeutic response and development of new treatments. Papers dealing with structure and function in animal models will also be considered if they reveal mechanisms that can be readily translated to human conditions.